Bridgefront Capital, LLC Albemarle Corp Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.77 - $135.46 $280,258 - $409,224	3,021 New	3,021 $288,000
Q2 2023 Aug 14, 2023	BUY	$172.91 - $232.22 $256,252 - $344,150	1,482 New	1,482 $330,000
Q2 2021 Aug 12, 2021	SELL	$143.7 - $176.01 $319,732 - $391,622	-2,225 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$140.69 - $185.25 $214,411 - $282,321	-1,524 Reduced 40.65%	2,225 $325,000
Q4 2020 Feb 12, 2021	BUY	$86.73 - $149.91 $325,150 - $562,012	3,749 New	3,749 $553,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.